We show that TREM-1 activation reprograms myeloid cells in the TME of PDAC toward an immunostimulatory phenotype, resulting in increased tumor-infiltrating lymphocyte activation and enhanced killing of tumor cells, thereby reducing tumor growth. The gene discussed is TREM1; the disease is neoplasm.